|
1
|
Black RL, Oglesby RB, von Sallmann L and
Bunim JJ: Posterior subcapsular cataracts induced by
corticosteroids in patients with rheumatoid arthritis. JAMA.
174:166–171. 1960. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Williamson J, Paterson RW, McGavin DD,
Jasani MK, Boyle JA and Doig WM: Posterior subcapsular cataracts
and glaucoma associated with long-term oral corticosteroid therapy.
In patients with rheumatoid arthritis and related conditions. Br J
Ophthalmol. 53:361–372. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Urban RC Jr and Cotlier E:
Corticosteroid-induced cataracts. Surv Ophthalmol. 31:102–110.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jobling AI and Augusteyn RC: What causes
steroid cataracts? A review of steroid-induced posterior
subcapsular cataracts. Clin Exp Optom. 85:61–75. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Auphan N, DiDonato JA, Rosette C, Helmberg
A and Karin M: Immunosuppression by glucocorticoids: inhibition of
NF-κB activity through induction of IκB synthesis. Science.
270:286–290. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ehrchen J, Steinmüller L, Barczyk K, et
al: Glucocorticoids induce differentiation of a specifically
activated, anti-inflammatory subtype of human monocytes. Blood.
109:1265–1274. 2007. View Article : Google Scholar
|
|
7
|
Reichardt HM, Tronche F, Berger S,
Kellendonk C and Schütz G: New insights into glucocorticoid and
mineralocorticoid signaling: lessons from gene targeting. Adv
Pharmacol. 47:1–21. 2000. View Article : Google Scholar
|
|
8
|
Aranda A and Pascual A: Nuclear hormone
receptors and gene expression. Physiol Rev. 81:1269–1304.
2001.PubMed/NCBI
|
|
9
|
Webster JC and Cidlowski JA: Mechanisms of
glucocorticoid-receptor-mediated repression of gene expression.
Trends Endocrinol Metab. 10:396–402. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nishigori H, Lee JW, Yamauchi Y and
Iwatsuru M: The alteration of lipid peroxide in
glucocorticoid-induced cataract of developing chick embryos and the
effect of ascorbic acid. Curr Eye Res. 5:37–40. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lou MF, Dickerson JE Jr, Garadi R and York
BM Jr: Glutathione depletion in the lens of galactosemic and
diabetic rats. Exp Eye Res. 46:517–530. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gupta V, Galante A, Soteropoulos P, Guo S
and Wagner BJ: Global gene profiling reveals novel glucocorticoid
induced changes in gene expression of human lens epithelial cells.
Mol Vis. 11:1018–1040. 2005.PubMed/NCBI
|
|
13
|
Gupta V, Awasthi N and Wagner BJ: Specific
activation of the glucocorticoid receptor and modulation of signal
transduction pathways in human lens epithelial cells. Invest
Ophthalmol Vis Sci. 48:1724–1734. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saklatvala J: Glucocorticoids: do we know
how they work? Arthritis Res. 4:146–150. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Keil JM, Liu X and Antonetti DA:
Glucocorticoid induction of occludin expression and endothelial
barrier requires transcription factor p54 NONO. Invest Ophthalmol
Vis Sci. 54:4007–4015. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Best CJ, Gillespie JW, Yi Y, et al:
Molecular alterations in primary prostate cancer after androgen
ablation therapy. Clin Cancer Res. 11:6823–6834. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Team RC: R: A language and environment for
statistical computing. Vienna, Austria: R Foundation for
Statistical Computing; pp. 1–1731. 2008
|
|
18
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy - analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reimers M and Carey VJ: Bioconductor: an
open source framework for bioinformatics and computational biology.
Methods Enzymol. 411:119–134. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sarle WS: Algorithms for clustering data.
Technometrics. 32:227–229. 1990. View Article : Google Scholar
|
|
22
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matys V, Fricke E, Geffers R, et al:
TRANSFAC: transcriptional regulation, from patterns to profiles.
Nucleic Acids Res. 31:374–378. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cumming RG, Mitchell P and Leeder SR: Use
of inhaled corticosteroids and the risk of cataracts. N Engl J Med.
337:8–14. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gu L, Tseng SC and Rollins BJ: Monocyte
chemoattractant protein-1. Chem Immunol. 72:7–29. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Poon M, Gertz SD, Fallon JT, et al:
Dexamethasone inhibits macrophage accumulation after balloon
arterial injury in cholesterol fed rabbits. Atherosclerosis.
155:371–380. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dhawan L, Liu B, Blaxall BC and Taubman
MB: A novel role for the glucocorticoid receptor in the regulation
of monocyte chemoattractant protein-1 mRNA stability. J Biol Chem.
282:10146–10152. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Janciauskiene S, Westin K, Grip O and
Krakau T: Detection of Alzheimer peptides and chemokines in the
aqueous humor. Eur J Ophthalmol. 21:104–111. 2011. View Article : Google Scholar
|
|
29
|
Boutros T, Chevet E and Metrakos P:
Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase
regulation: roles in cell growth, death, and cancer. Pharmacol Rev.
60:261–310. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Abraham SM, Lawrence T, Kleiman A, et al:
Antiinflammatory effects of dexamethasone are partly dependent on
induction of dual specificity phosphatase 1. J Exp Med.
203:1883–1889. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagata S: Fas and Fas ligand: a death
factor and its receptor. Adv Immunol. 57:129–144. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang Y, Merćep M, Ware CF and Ashwell JD:
Fas and activation-induced Fas ligand mediate apoptosis of T cell
hybridomas: inhibition of Fas ligand expression by retinoic acid
and glucocorticoids. J Exp Med. 181:1673–1682. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wisdom R, Johnson RS and Moore C: c-Jun
regulates cell cycle progression and apoptosis by distinct
mechanisms. EMBO J. 18:188–197. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakayama K, Furusu A, Xu Q, Konta T and
Kitamura M: Unexpected transcriptional induction of monocyte
chemoattractant protein 1 by proteasome inhibition: involvement of
the c-Jun N-terminal kinase-activator protein 1 pathway. J Immunol.
167:1145–1150. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Erhardt A, Hassan M, Heintges T and
Häussinger D: Hepatitis C virus core protein induces cell
proliferation and activates ERK, JNK, and p38 MAP kinases together
with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line.
Virology. 292:272–284. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Herdegen T, Claret FX, Kallunki T, et al:
Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun
N-terminal kinases after neuronal injury. J Neurosci. 18:5124–5135.
1998.PubMed/NCBI
|
